PPAR-γ agonist attenuates inflammation in aortic aneurysm patients (Q40693751)

22 September 2017

PPAR-γ agonist attenuates inflammation in aortic aneurysm patients (English)

1 reference

22 September 2017

Tatsuo Motoki

1

1 reference

22 September 2017

Hirotsugu Kurobe

2

1 reference

22 September 2017

Yoichiro Hirata

3

1 reference

22 September 2017

Taisuke Nakayama

4

1 reference

22 September 2017

Hajime Kinoshita

5

1 reference

22 September 2017

Kevin A Rocco

6

1 reference

22 September 2017

Hitoshi Sogabe

7

1 reference

22 September 2017

Takaki Hori

8

1 reference

22 September 2017

Masataka Sata

9

1 reference

22 September 2017

Tetsuya Kitagawa

10

1 reference

22 September 2017

27 July 2015

1 reference

General thoracic and cardiovascular surgery

22 September 2017

1 reference

22 September 2017

63

1 reference

22 September 2017

565-571

1 reference

22 September 2017

10

1 reference

https://scigraph.springernature.com/pub.10.1007/s11748-015-0576-1

22 September 2017

0 references

cites work

Thoracic and cardiovascular surgery in Japan during 2010 : annual report by The Japanese Association for Thoracic Surgery.

1 reference

https://api.crossref.org/works/10.1007%2FS11748-015-0576-1

Thoracic and abdominal aortic aneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-015-0576-1

Genetic and epigenetic mechanisms and their possible role in abdominal aortic aneurysm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-015-0576-1

Inflammation in abdominal aortic aneurysms: cellular infiltrate and cytokine profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-015-0576-1

Diagnostic and therapeutic strategies for small abdominal aortic aneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-015-0576-1

Pathophysiology and epidemiology of abdominal aortic aneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-015-0576-1

Abdominal aortic aneurysms: an autoimmune disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-015-0576-1

Thiazolidinediones: effects on insulin resistance and the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-015-0576-1

Role of peroxisome proliferator-activated receptor-γ in atherosclerosis: an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-015-0576-1

Reassessing the cardiovascular risks and benefits of thiazolidinediones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-015-0576-1

Systematic review of guidelines on abdominal aortic aneurysm screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-015-0576-1

Imaging aortic aneurysmal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-015-0576-1

A prospective study of growth and rupture risk of small-to-moderate size ascending aortic aneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-015-0576-1

Pharmacological treatment of abdominal aortic aneurysm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-015-0576-1

Azelnidipine suppresses the progression of aortic aneurysm in wild mice model through anti-inflammatory effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-015-0576-1

Abdominal aortic aneurysm: pathogenesis and implications for management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-015-0576-1

Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-015-0576-1

The role of PPARs in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-015-0576-1

Macrophage polarization and insulin resistance: PPARgamma in control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-015-0576-1

Macrophage polarization in inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-015-0576-1

Macrophage plasticity and polarization: in vivo veritas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-015-0576-1

PPAR- γ agonist in treatment of diabetes: cardiovascular safety considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-015-0576-1

Peroxisome proliferator-activated receptor agonists and bladder cancer: lessons from animal studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-015-0576-1

The antidiabetic drug ciglitazone induces high grade bladder cancer cells apoptosis through the up-regulation of TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-015-0576-1

Screening of abdominal aortic aneurysms

21 January 2018

1 reference

12 December 2020

Acute aortic syndromes: definition, prognosis and treatment options

1 reference

12 December 2020

The impact of stent graft evolution on the results of endovascular abdominal aortic aneurysm repair

1 reference

12 December 2020

Hyperplastic cellular remodeling of the media in ascending thoracic aortic aneurysms

1 reference

12 December 2020

10.1007/S11748-015-0576-1

Identifiers

DOI

1 reference

22 September 2017

1 reference